Internal Medicine, Hematology & Oncology · Steubenville, OH
NPI
1952375578
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3204 Johnson Rd, Teramana Cancer Center
Steubenville, OH, 43952
Phone (740) 266-3900
Groups this clinician bills Medicare through
Medicare paid, 2024
$123K
1,844 services
Medicare patients, 2024
476
Average age 75
Drug cost, 2024
$4.0M
1,641 prescriptions
Company payments, 2025
$669
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammad P Rahman was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 604 times for 351 patients. In total Mohammad P Rahman billed 1,844 services in 13 codes, and Medicare paid $123K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-04-06.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 604 | 351 | $12.40 | $7,489 |
| 99215 Office E&M - Established | Facility | 560 | 272 | $104.67 | $59K |
| 99214 Office E&M - Established | Facility | 180 | 160 | $63.31 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 176 | 68 | $89.13 | $16K |
| 99223 Hospital E&M - Initial | Facility | 110 | 75 | $130.70 | $14K |
| 99213 Office E&M - Established | Facility | 94 | 87 | $39.16 | $3,681 |
| 99205 Office E&M - New | Facility | 66 | 66 | $128.30 | $8,468 |
| 99232 Hospital E&M - Subsequent | Facility | 33 | 21 | $59.03 | $1,948 |
By year: 2022 $98K for 1,170 services; 2023 $101K for 1,247 services; 2024 $123K for 1,844 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mohammad P Rahman prescribed most often to Medicare patients was Anastrozole, with 195 prescriptions and refills. In total Mohammad P Rahman wrote 1,641 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 195 | 388 | 63 | $2,391 |
| Eliquis Apixaban | 120 | 164 | 30 | $95K |
| Ondansetron Hcl Generic | 96 | 96 | 67 | $4,514 |
| Exemestane Generic | 93 | 159 | 21 | $11K |
| Prednisone Generic | 91 | 107 | 30 | $391 |
| Ibrance Palbociclib | 75 | 75 | 12 | $1.1M |
| Abiraterone Acetate Generic | 47 | 47 | Under 11 | $112K |
| Letrozole Generic | 44 | 82 | Under 11 | $687 |
| Oxycodone Hcl Generic | 42 | 42 | 25 | $567 |
| Acyclovir Generic | 40 | 56 | 11 | $665 |
| Promacta Eltrombopag Olamine | 38 | 38 | Under 11 | $346K |
| Xarelto Rivaroxaban | 37 | 55 | Under 11 | $32K |
| Imatinib Mesylate Generic | 36 | 36 | Under 11 | $20K |
| Pantoprazole Sodium Generic | 34 | 54 | Under 11 | $176 |
| Prochlorperazine Maleate Generic | 34 | 34 | 15 | $791 |
Brand drugs: 446 claims; generic drugs: 1,195 claims; opioid claims: 86.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammad P Rahman $669 ($669 in general payments such as food, travel and fees) from 16 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $145.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $145 |
| Seagen Inc. PFE | 1 | $99.99 |
| Incyte Corporation INCY | 2 | $49.45 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $38.1 |
| Merck Sharp & Dohme LLC MRK | 2 | $33.74 |
| Exelixis Inc. EXEL | 1 | $33.31 |
| Astellas Pharma US Inc 4503.T | 1 | $33.05 |
| Abbvie Inc. ABBV | 1 | $29.42 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $28.15 |
| Pfizer Inc. PFE | 3 | $27.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.